Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Genetics Institute's factor IX scheduled for review

Nov. 21, 1996

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

CAPRIE study demonstrates clopidogrel more effective than aspirin

Nov. 15, 1996

Preclinical and clinical pharmacological profile of efegatran

Nov. 15, 1996

Ciba-Geigy describes trypsin/thrombin inhibitors

Nov. 15, 1996

FDA clears new heart attack drug

Nov. 8, 1996

Japanese researchers report potential fibrinolytic agent

Nov. 8, 1996

Novel PAI-1 inhibitor discovered by Xenova

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...